硫化在高血压状态下通过SIRT6抗炎信号来改善血管内皮功能
Fan Lu1, Xueyuan Qin1,2, Shanshan Lu1
1Department of Physiology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Acta biochimica et biophysica Sinica
|November 25, 2025
概括
硫化 (H2S) 通过恢复sirtuin 6 (SIRT6) 表达和抑制炎症,防止高血压引起的内皮功能障碍. 这项研究强调了H2S作为血管健康的潜在治疗剂.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 内分泌学 在内分泌学.
背景情况:
- 高血压经常导致内皮功能障碍,标志着血管扩张受损和炎症增加.
- 关键标志物包括氧化物 (NO) 生物可用性降低和高素-6 (IL-6) 和细胞间粘附分子-1 (ICAM-1).
研究的目的:
- 调查硫化 (H2S) 在血管激素II (Ang II) 诱导的内皮功能障碍中的保护作用.
- 阐明涉及素6 (SIRT6) 的潜在分子机制.
主要方法:
- 使用Ang II诱导的内皮功能障碍的小鼠模型.
- 给H2S捐赠者GYY4137和使用内皮特异性cystathionine-γ-lyase (CSE) 缺乏的小鼠.
- 评估了H2S和SIRT6抑制对血管功能和炎症的影响.
主要成果:
- GYY4137治疗逆转了Ang II诱导的内皮损伤,抑制了炎症,并改善了血管扩张功能.
- 在CSE缺乏的小鼠中,H2S补充改善了炎症和内皮功能障碍.
- 抑制SIRT6消除了H2S的保护作用,表明其关键作用.
结论:
- 硫化 (H2S) 通过激活SIRT6抗炎途径来保护血管内皮功能.
- H2S捐赠者GYY4137证明了与高血压相关的内皮功能障碍的治疗潜力.
- SIRT6是H2S诱导的血管保护的关键媒介.
相关概念视频
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Hypertension II: Pathophysiology
763
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
763
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
538
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
538
Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K


